Search results
Results from the WOW.Com Content Network
Noubar Afeyan (Western Armenian: Նուպար Աֆէեան; born in 1962) is an American-Canadian entrepreneur, inventor, and philanthropist. [1] [2] He is best known for co-founding the biotechnology company Moderna, through his venture capital firm, Flagship Pioneering, and for co-founding humanitarian projects such as Aurora Prize and The Future Armenian.
Before joining Moderna, Bancel was the CEO of French diagnostics company BioMérieux. Bancel is a partner at Flagship Pioneering, and has served on the boards of Indigo Agriculture, Boston's Museum of Science, and Qiagen. As of May 2023, his net worth was estimated at US$4.1 billion, owning about 8% of Moderna. [2]
In July 2018, the company opened a 200,000 square foot facility in Norwood, Massachusetts for manufacturing, preclinical and clinical work. [24] In December 2018, Moderna became a public company via the largest initial public offering of a biotechnology company in history, raising $621 million by selling 27 million shares at $23 per share. [25 ...
But retaining a top 20 spot has required them to grow dramatically more wealthy since 2000. For example, Ellison's net worth has more than quadrupled from $47 billion to $217 billion. Buffett's ...
Net worth: $220.8 billion Larry Ellison, the founder and chief technology officer of Oracle, gained $11.7 billion as Oracle shares rallied with the broader tech sector. The stock ended the day 5.5 ...
Net worth: $245B. 2. Jeff Bezos, Amazon and Blue Origin founder Net worth: $201B. 3. Bernard Arnault, LVMH founder and CEO Net worth: $197B. 4. Mark Zuckerberg, Meta cofounder and CEO Net worth ...
He is the most cited engineer in history [8] and one of the 10 most cited individuals in any field, [9] having authored over 1,500 scientific papers. Langer is also a prolific businessman, having been behind the participation in the founding of over 40 biotechnology companies including the well-known American pharmaceutical company, Moderna.
(Reuters) - Robert Langer, co-founder and a key figure behind Moderna's scientific success, will step down from the vaccine maker's board on Aug. 5, the company said on Tuesday.